We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · April 05, 2018

Comparative Survival Following Initial Cytoreductive Nephrectomy vs Initial Targeted Therapy for Metastatic RCC

The Journal of Urology

 

Additional Info

The Journal of Urology
Comparative Survival Following Initial Cytoreductive Nephrectomy Versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma
J Urol 2018 Mar 21;[EPub Ahead of Print], B Bhindi, EB Habermann, RJ Mason, BA Costello, LC Pagliaro, RH Thompson, BC Leibovich, SA Boorjian

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading